論文 2024年

2023年

英文

  1. Shiomi I, Makuuchi Y, Noura I, Kakuno S, Niki M, Kaimi Y, Ido K, Sakatoku K, Kuno M, Takakuwa T, Okamura H, Nishimoto M, Nakashima Y, Nakamae M, Kakeya H, Kohashi K, Hino M, Nakamae H. Invasive fungal infection caused by Blastobotrys mokoenaii in an immunocompromised patient with acute myeloid leukemia: A case report. J Infect Chemother. 2024 Jun;30(6):557-561. doi: 10.1016/j.jiac.2023.12.002. Epub 2023 Dec 11.
  2. Kobayashi K, Hata A, Imoto W, Kakuno S, Shibata W, Yamada K, Kawaguchi H, Sakurai N, Ito T, Uenoyama K, Takahashi T, Ueda S, Katayama T, Onoue M, Kakeya H. Evaluation of predictors of third-generation cephalosporin non-susceptibility and factors affecting recurrence or death in bacteremia caused by Citrobacter freundii complex , Enterobacter cloacae complex, and Klebsiella aerogenes. J Chemother. 2024 Mar 7:1-11. doi: 10.1080/1120009X.2024.2323326. Online ahead of print.
  3. Matsuura T, Fukushima W, Nakagama Y, Kido Y, Kase T, Kondo K, Kaku N, Matsumoto K, Suita A, Mukai E, Nitahara Y, Konishi A, Kasamatsu A, Nakagama S, Nakagami-Yamaguchi E, Ohfuji S, Kaneko Y, Kaneko A, Kakeya H, Hirota Y. Factors impacting antibody kinetics, including fever and vaccination intervals, in SARS-CoV-2-naïve adults receiving the first four mRNA COVID-19 vaccine doses. Sci Rep. 2024 Mar 27;14(1):7217. doi: 10.1038/s41598-024-57931-0.
  4. Imoto W, Ihara Y, Imai T, Tamato M, Ibuki T, Yamada K, Kaneko Y, Shintani A, Kakeya H. Evaluating the association of body mass index with COVID-19 severity and mortality using Japanese administrative claims data. J Infect Chemother, 2024 Apr 16:S1341-321X(24)00115-6. doi: 10.1016/j.jiac.2024.04.007. Online ahead of print.

和文

  1. 掛屋 弘. 予防接種の安全性と有効性. 今日の治療指針2024. 医学書院 2024, pp229-232.